PIRAMAL PHARMA
Back to Income Statement
|
PIRAMAL PHARMA Last 5 Year Revenue History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Net Sales | ₹8,869 Cr | ₹9,151 Cr | ₹8,171 Cr | ₹7,082 Cr | ₹6,559 Cr |
What is the latest Revenue of PIRAMAL PHARMA ?
| Year | Revenue |
|---|---|
| Mar2026 | ₹8,869 Cr |
| Mar2025 | ₹9,151 Cr |
| Mar2024 | ₹8,171 Cr |
| Mar2023 | ₹7,082 Cr |
| Mar2022 | ₹6,559 Cr |
How is Revenue of PIRAMAL PHARMA Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2026 | ₹8,869 Cr | -3.08 | |
| Mar2025 | ₹9,151 Cr | 11.99 | |
| Mar2024 | ₹8,171 Cr | 15.39 | |
| Mar2023 | ₹7,082 Cr | 7.97 | |
| Mar2022 | ₹6,559 Cr | - | |
Compare Revenue of peers of PIRAMAL PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| PIRAMAL PHARMA | ₹23,311.1 Cr | 3.9% | 5% | -12.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹456,593.0 Cr | 2% | 6.7% | 14.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹179,737.0 Cr | 3.5% | 2.2% | 0.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹164,290.0 Cr | 4.6% | 9.9% | 41.5% | Stock Analytics | |
| CIPLA | ₹117,327.0 Cr | -0.3% | 3.7% | -2.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹112,994.0 Cr | 1.1% | 5.9% | 6.6% | Stock Analytics | |
PIRAMAL PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| PIRAMAL PHARMA | 3.9% |
5% |
-12.5% |
| SENSEX | 2.2% |
5.1% |
-7% |
You may also like the below Video Courses